nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP4A11—Cisplatin—hematologic cancer	0.0424	0.0692	CbGbCtD
Pentamidine—CYP4A11—Dexamethasone—hematologic cancer	0.0343	0.0559	CbGbCtD
Pentamidine—CYP1A2—Anagrelide—hematologic cancer	0.0218	0.0355	CbGbCtD
Pentamidine—CYP1A1—Methoxsalen—hematologic cancer	0.0218	0.0355	CbGbCtD
Pentamidine—CYP1A1—Bortezomib—hematologic cancer	0.0207	0.0338	CbGbCtD
Pentamidine—CYP1A1—Daunorubicin—hematologic cancer	0.0198	0.0323	CbGbCtD
Pentamidine—CYP1A1—Thalidomide—hematologic cancer	0.018	0.0294	CbGbCtD
Pentamidine—CYP1A1—Dacarbazine—hematologic cancer	0.0155	0.0253	CbGbCtD
Pentamidine—CYP1A1—Dasatinib—hematologic cancer	0.0122	0.0199	CbGbCtD
Pentamidine—CYP2C8—Bortezomib—hematologic cancer	0.012	0.0195	CbGbCtD
Pentamidine—CYP3A5—Daunorubicin—hematologic cancer	0.0119	0.0194	CbGbCtD
Pentamidine—CYP2D6—Lomustine—hematologic cancer	0.0116	0.0189	CbGbCtD
Pentamidine—CYP1A2—Carmustine—hematologic cancer	0.0114	0.0187	CbGbCtD
Pentamidine—CYP3A5—Thalidomide—hematologic cancer	0.0108	0.0177	CbGbCtD
Pentamidine—CYP3A5—Teniposide—hematologic cancer	0.0103	0.0169	CbGbCtD
Pentamidine—CYP2D6—Idarubicin—hematologic cancer	0.0103	0.0168	CbGbCtD
Pentamidine—CYP2C19—Bortezomib—hematologic cancer	0.01	0.0164	CbGbCtD
Pentamidine—CYP1A2—Methoxsalen—hematologic cancer	0.00973	0.0159	CbGbCtD
Pentamidine—CYP3A5—Ifosfamide—hematologic cancer	0.00954	0.0156	CbGbCtD
Pentamidine—TRDMT1—hematopoietic system—hematologic cancer	0.00947	0.194	CbGeAlD
Pentamidine—CYP1A2—Bortezomib—hematologic cancer	0.00925	0.0151	CbGbCtD
Pentamidine—CYP2C8—Ifosfamide—hematologic cancer	0.00917	0.015	CbGbCtD
Pentamidine—CYP3A5—Imatinib—hematologic cancer	0.00911	0.0149	CbGbCtD
Pentamidine—CYP1A2—Daunorubicin—hematologic cancer	0.00885	0.0144	CbGbCtD
Pentamidine—CYP2D6—Hydroxyurea—hematologic cancer	0.00876	0.0143	CbGbCtD
Pentamidine—CYP2C19—Thalidomide—hematologic cancer	0.00874	0.0143	CbGbCtD
Pentamidine—CYP1A2—Alitretinoin—hematologic cancer	0.00867	0.0141	CbGbCtD
Pentamidine—CYP2C19—Teniposide—hematologic cancer	0.00833	0.0136	CbGbCtD
Pentamidine—CYP1A2—Thalidomide—hematologic cancer	0.00806	0.0131	CbGbCtD
Pentamidine—CYP2C8—Nilotinib—hematologic cancer	0.00796	0.013	CbGbCtD
Pentamidine—CYP3A4—Bexarotene—hematologic cancer	0.00791	0.0129	CbGbCtD
Pentamidine—CYP2C19—Ifosfamide—hematologic cancer	0.00769	0.0125	CbGbCtD
Pentamidine—CYP2D6—Bortezomib—hematologic cancer	0.00762	0.0124	CbGbCtD
Pentamidine—CYP3A4—Busulfan—hematologic cancer	0.00735	0.012	CbGbCtD
Pentamidine—CYP3A4—Lomustine—hematologic cancer	0.00735	0.012	CbGbCtD
Pentamidine—CYP2C19—Imatinib—hematologic cancer	0.00735	0.012	CbGbCtD
Pentamidine—CYP3A5—Dasatinib—hematologic cancer	0.00732	0.0119	CbGbCtD
Pentamidine—CYP1A2—Dacarbazine—hematologic cancer	0.00693	0.0113	CbGbCtD
Pentamidine—CYP1A2—Imatinib—hematologic cancer	0.00678	0.0111	CbGbCtD
Pentamidine—CYP3A4—Thiotepa—hematologic cancer	0.00655	0.0107	CbGbCtD
Pentamidine—TRDMT1—blood—hematologic cancer	0.00627	0.128	CbGeAlD
Pentamidine—CYP1A1—Dexamethasone—hematologic cancer	0.00624	0.0102	CbGbCtD
Pentamidine—CYP3A5—Irinotecan—hematologic cancer	0.00569	0.00928	CbGbCtD
Pentamidine—CYP2D6—Imatinib—hematologic cancer	0.00559	0.00911	CbGbCtD
Pentamidine—CYP1A2—Dasatinib—hematologic cancer	0.00545	0.00888	CbGbCtD
Pentamidine—CYP3A4—Methoxsalen—hematologic cancer	0.0051	0.00831	CbGbCtD
Pentamidine—CYP2D6—Nilotinib—hematologic cancer	0.00508	0.00828	CbGbCtD
Pentamidine—CYP2D6—Vinorelbine—hematologic cancer	0.00503	0.00821	CbGbCtD
Pentamidine—CYP3A5—Vincristine—hematologic cancer	0.00497	0.00811	CbGbCtD
Pentamidine—CYP3A4—Bortezomib—hematologic cancer	0.00485	0.00791	CbGbCtD
Pentamidine—CYP2C19—Prednisone—hematologic cancer	0.00484	0.0079	CbGbCtD
Pentamidine—CYP3A4—Daunorubicin—hematologic cancer	0.00464	0.00756	CbGbCtD
Pentamidine—CYP3A5—Etoposide—hematologic cancer	0.00456	0.00743	CbGbCtD
Pentamidine—CYP2C8—Etoposide—hematologic cancer	0.00438	0.00715	CbGbCtD
Pentamidine—AOC1—hematopoietic system—hematologic cancer	0.00427	0.0874	CbGeAlD
Pentamidine—CYP3A4—Cytarabine—hematologic cancer	0.00409	0.00667	CbGbCtD
Pentamidine—CYP3A4—Teniposide—hematologic cancer	0.00403	0.00657	CbGbCtD
Pentamidine—CYP3A5—Dexamethasone—hematologic cancer	0.00375	0.00611	CbGbCtD
Pentamidine—S100B—hematopoietic system—hematologic cancer	0.00372	0.0762	CbGeAlD
Pentamidine—CYP3A4—Ifosfamide—hematologic cancer	0.00372	0.00607	CbGbCtD
Pentamidine—CYP2C8—Dexamethasone—hematologic cancer	0.0036	0.00588	CbGbCtD
Pentamidine—CYP3A4—Imatinib—hematologic cancer	0.00355	0.00579	CbGbCtD
Pentamidine—CYP1A2—Etoposide—hematologic cancer	0.00339	0.00553	CbGbCtD
Pentamidine—CYP3A4—Ruxolitinib—hematologic cancer	0.00334	0.00546	CbGbCtD
Pentamidine—CYP3A4—Nilotinib—hematologic cancer	0.00323	0.00527	CbGbCtD
Pentamidine—CYP3A4—Vinorelbine—hematologic cancer	0.0032	0.00522	CbGbCtD
Pentamidine—CYP2D6—Vinblastine—hematologic cancer	0.0031	0.00506	CbGbCtD
Pentamidine—CYP2C19—Dexamethasone—hematologic cancer	0.00302	0.00493	CbGbCtD
Pentamidine—CYP3A4—Triamcinolone—hematologic cancer	0.00293	0.00478	CbGbCtD
Pentamidine—CYP3A4—Dasatinib—hematologic cancer	0.00285	0.00465	CbGbCtD
Pentamidine—AOC1—blood—hematologic cancer	0.00283	0.0579	CbGeAlD
Pentamidine—CYP3A4—Mitoxantrone—hematologic cancer	0.00282	0.0046	CbGbCtD
Pentamidine—AOC1—bone marrow—hematologic cancer	0.00273	0.056	CbGeAlD
Pentamidine—CYP3A4—Betamethasone—hematologic cancer	0.00251	0.0041	CbGbCtD
Pentamidine—CYP3A4—Prednisolone—hematologic cancer	0.00248	0.00404	CbGbCtD
Pentamidine—S100B—blood—hematologic cancer	0.00246	0.0505	CbGeAlD
Pentamidine—CYP3A4—Prednisone—hematologic cancer	0.00234	0.00382	CbGbCtD
Pentamidine—AOC1—testis—hematologic cancer	0.00234	0.0479	CbGeAlD
Pentamidine—CYP2D6—Dexamethasone—hematologic cancer	0.0023	0.00375	CbGbCtD
Pentamidine—CYP3A4—Irinotecan—hematologic cancer	0.00222	0.00362	CbGbCtD
Pentamidine—CYP3A4—Vinblastine—hematologic cancer	0.00197	0.00322	CbGbCtD
Pentamidine—CYP3A4—Vincristine—hematologic cancer	0.00194	0.00316	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—hematologic cancer	0.00191	0.00311	CbGbCtD
Pentamidine—CYP3A4—Etoposide—hematologic cancer	0.00178	0.0029	CbGbCtD
Pentamidine—AOC1—lymph node—hematologic cancer	0.00169	0.0347	CbGeAlD
Pentamidine—S100B—lymph node—hematologic cancer	0.00148	0.0303	CbGeAlD
Pentamidine—CYP3A4—Dexamethasone—hematologic cancer	0.00146	0.00238	CbGbCtD
Pentamidine—CYP3A4—Doxorubicin—hematologic cancer	0.00121	0.00198	CbGbCtD
Pentamidine—CYP2C19—hematopoietic system—hematologic cancer	0.000998	0.0204	CbGeAlD
Pentamidine—CYP2C8—hematopoietic system—hematologic cancer	0.000871	0.0178	CbGeAlD
Pentamidine—CYP1A2—hematopoietic system—hematologic cancer	0.000815	0.0167	CbGeAlD
Pentamidine—CYP1A1—hematopoietic system—hematologic cancer	0.000804	0.0165	CbGeAlD
Pentamidine—CYP3A5—hematopoietic system—hematologic cancer	0.000786	0.0161	CbGeAlD
Pentamidine—Ospemifene—ESR1—hematologic cancer	0.000763	1	CrCbGaD
Pentamidine—CYP2C19—blood—hematologic cancer	0.000661	0.0135	CbGeAlD
Pentamidine—CYP3A4—hematopoietic system—hematologic cancer	0.00059	0.0121	CbGeAlD
Pentamidine—CYP2D6—hematopoietic system—hematologic cancer	0.00058	0.0119	CbGeAlD
Pentamidine—CYP2C8—blood—hematologic cancer	0.000577	0.0118	CbGeAlD
Pentamidine—CYP1A2—blood—hematologic cancer	0.00054	0.0111	CbGeAlD
Pentamidine—CYP1A1—blood—hematologic cancer	0.000532	0.0109	CbGeAlD
Pentamidine—CYP3A5—blood—hematologic cancer	0.000521	0.0107	CbGeAlD
Pentamidine—CYP2C8—testis—hematologic cancer	0.000477	0.00977	CbGeAlD
Pentamidine—CYP1A2—lung—hematologic cancer	0.000473	0.00969	CbGeAlD
Pentamidine—CYP1A1—lung—hematologic cancer	0.000467	0.00956	CbGeAlD
Pentamidine—CYP3A5—lung—hematologic cancer	0.000456	0.00935	CbGeAlD
Pentamidine—CYP3A4—blood—hematologic cancer	0.000391	0.008	CbGeAlD
Pentamidine—CYP2D6—blood—hematologic cancer	0.000384	0.00788	CbGeAlD
Pentamidine—CYP1A1—lymph node—hematologic cancer	0.000319	0.00654	CbGeAlD
Pentamidine—CYP2D6—testis—hematologic cancer	0.000318	0.00651	CbGeAlD
Pentamidine—Pharyngitis—Doxorubicin—hematologic cancer	2.06e-05	8e-05	CcSEcCtD
Pentamidine—Dyspepsia—Dexamethasone—hematologic cancer	2.06e-05	7.99e-05	CcSEcCtD
Pentamidine—Dyspepsia—Betamethasone—hematologic cancer	2.06e-05	7.99e-05	CcSEcCtD
Pentamidine—Urticaria—Triamcinolone—hematologic cancer	2.05e-05	7.95e-05	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—hematologic cancer	2.04e-05	7.94e-05	CcSEcCtD
Pentamidine—Dysgeusia—Methotrexate—hematologic cancer	2.04e-05	7.93e-05	CcSEcCtD
Pentamidine—Asthenia—Etoposide—hematologic cancer	2.04e-05	7.92e-05	CcSEcCtD
Pentamidine—Body temperature increased—Triamcinolone—hematologic cancer	2.04e-05	7.91e-05	CcSEcCtD
Pentamidine—Anaphylactic shock—Prednisone—hematologic cancer	2.04e-05	7.91e-05	CcSEcCtD
Pentamidine—Decreased appetite—Dexamethasone—hematologic cancer	2.03e-05	7.89e-05	CcSEcCtD
Pentamidine—Decreased appetite—Betamethasone—hematologic cancer	2.03e-05	7.89e-05	CcSEcCtD
Pentamidine—Nausea—Irinotecan—hematologic cancer	2.03e-05	7.88e-05	CcSEcCtD
Pentamidine—Nausea—Mitoxantrone—hematologic cancer	2.03e-05	7.88e-05	CcSEcCtD
Pentamidine—Infection—Prednisone—hematologic cancer	2.02e-05	7.86e-05	CcSEcCtD
Pentamidine—Fatigue—Dexamethasone—hematologic cancer	2.02e-05	7.83e-05	CcSEcCtD
Pentamidine—Fatigue—Betamethasone—hematologic cancer	2.02e-05	7.83e-05	CcSEcCtD
Pentamidine—Chills—Epirubicin—hematologic cancer	2.01e-05	7.81e-05	CcSEcCtD
Pentamidine—Pruritus—Etoposide—hematologic cancer	2.01e-05	7.81e-05	CcSEcCtD
Pentamidine—Shock—Prednisone—hematologic cancer	2e-05	7.78e-05	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—hematologic cancer	2e-05	7.78e-05	CcSEcCtD
Pentamidine—Pain—Dexamethasone—hematologic cancer	2e-05	7.77e-05	CcSEcCtD
Pentamidine—Pain—Betamethasone—hematologic cancer	2e-05	7.77e-05	CcSEcCtD
Pentamidine—Tachycardia—Prednisone—hematologic cancer	1.99e-05	7.72e-05	CcSEcCtD
Pentamidine—Nausea—Gemcitabine—hematologic cancer	1.98e-05	7.68e-05	CcSEcCtD
Pentamidine—Vomiting—Cisplatin—hematologic cancer	1.97e-05	7.66e-05	CcSEcCtD
Pentamidine—Vision blurred—Methotrexate—hematologic cancer	1.97e-05	7.63e-05	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—hematologic cancer	1.96e-05	7.62e-05	CcSEcCtD
Pentamidine—Rash—Cisplatin—hematologic cancer	1.96e-05	7.59e-05	CcSEcCtD
Pentamidine—Dermatitis—Cisplatin—hematologic cancer	1.95e-05	7.59e-05	CcSEcCtD
Pentamidine—Erythema—Epirubicin—hematologic cancer	1.95e-05	7.58e-05	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—hematologic cancer	1.94e-05	7.55e-05	CcSEcCtD
Pentamidine—Anorexia—Prednisone—hematologic cancer	1.94e-05	7.54e-05	CcSEcCtD
Pentamidine—Anaemia—Methotrexate—hematologic cancer	1.93e-05	7.49e-05	CcSEcCtD
Pentamidine—Feeling abnormal—Dexamethasone—hematologic cancer	1.93e-05	7.48e-05	CcSEcCtD
Pentamidine—Feeling abnormal—Betamethasone—hematologic cancer	1.93e-05	7.48e-05	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—hematologic cancer	1.93e-05	7.48e-05	CcSEcCtD
Pentamidine—Tension—Epirubicin—hematologic cancer	1.92e-05	7.44e-05	CcSEcCtD
Pentamidine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.91e-05	7.43e-05	CcSEcCtD
Pentamidine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.91e-05	7.43e-05	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—hematologic cancer	1.91e-05	7.42e-05	CcSEcCtD
Pentamidine—Hypersensitivity—Triamcinolone—hematologic cancer	1.9e-05	7.37e-05	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—hematologic cancer	1.9e-05	7.36e-05	CcSEcCtD
Pentamidine—Dizziness—Etoposide—hematologic cancer	1.88e-05	7.3e-05	CcSEcCtD
Pentamidine—Vertigo—Methotrexate—hematologic cancer	1.87e-05	7.28e-05	CcSEcCtD
Pentamidine—Leukopenia—Methotrexate—hematologic cancer	1.87e-05	7.25e-05	CcSEcCtD
Pentamidine—Chills—Doxorubicin—hematologic cancer	1.86e-05	7.23e-05	CcSEcCtD
Pentamidine—Urticaria—Dexamethasone—hematologic cancer	1.86e-05	7.21e-05	CcSEcCtD
Pentamidine—Urticaria—Betamethasone—hematologic cancer	1.86e-05	7.21e-05	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.86e-05	7.21e-05	CcSEcCtD
Pentamidine—Dizziness—Prednisolone—hematologic cancer	1.85e-05	7.2e-05	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—hematologic cancer	1.85e-05	7.2e-05	CcSEcCtD
Pentamidine—Asthenia—Triamcinolone—hematologic cancer	1.85e-05	7.18e-05	CcSEcCtD
Pentamidine—Body temperature increased—Dexamethasone—hematologic cancer	1.85e-05	7.18e-05	CcSEcCtD
Pentamidine—Abdominal pain—Dexamethasone—hematologic cancer	1.85e-05	7.18e-05	CcSEcCtD
Pentamidine—Abdominal pain—Betamethasone—hematologic cancer	1.85e-05	7.18e-05	CcSEcCtD
Pentamidine—Body temperature increased—Betamethasone—hematologic cancer	1.85e-05	7.18e-05	CcSEcCtD
Pentamidine—Nausea—Cisplatin—hematologic cancer	1.84e-05	7.15e-05	CcSEcCtD
Pentamidine—Insomnia—Prednisone—hematologic cancer	1.84e-05	7.15e-05	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—hematologic cancer	1.84e-05	7.14e-05	CcSEcCtD
Pentamidine—Paraesthesia—Prednisone—hematologic cancer	1.83e-05	7.1e-05	CcSEcCtD
Pentamidine—Pruritus—Triamcinolone—hematologic cancer	1.82e-05	7.08e-05	CcSEcCtD
Pentamidine—Cough—Methotrexate—hematologic cancer	1.82e-05	7.07e-05	CcSEcCtD
Pentamidine—Convulsion—Methotrexate—hematologic cancer	1.81e-05	7.02e-05	CcSEcCtD
Pentamidine—Vomiting—Etoposide—hematologic cancer	1.81e-05	7.02e-05	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—hematologic cancer	1.81e-05	7.01e-05	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—hematologic cancer	1.8e-05	7e-05	CcSEcCtD
Pentamidine—Dyspepsia—Prednisone—hematologic cancer	1.79e-05	6.96e-05	CcSEcCtD
Pentamidine—Rash—Etoposide—hematologic cancer	1.79e-05	6.96e-05	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—hematologic cancer	1.79e-05	6.95e-05	CcSEcCtD
Pentamidine—Headache—Etoposide—hematologic cancer	1.78e-05	6.91e-05	CcSEcCtD
Pentamidine—Arthralgia—Methotrexate—hematologic cancer	1.78e-05	6.89e-05	CcSEcCtD
Pentamidine—Chest pain—Methotrexate—hematologic cancer	1.78e-05	6.89e-05	CcSEcCtD
Pentamidine—Myalgia—Methotrexate—hematologic cancer	1.78e-05	6.89e-05	CcSEcCtD
Pentamidine—Tension—Doxorubicin—hematologic cancer	1.77e-05	6.88e-05	CcSEcCtD
Pentamidine—Decreased appetite—Prednisone—hematologic cancer	1.77e-05	6.87e-05	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—hematologic cancer	1.77e-05	6.87e-05	CcSEcCtD
Pentamidine—Rash—Prednisolone—hematologic cancer	1.77e-05	6.86e-05	CcSEcCtD
Pentamidine—Dermatitis—Prednisolone—hematologic cancer	1.77e-05	6.86e-05	CcSEcCtD
Pentamidine—Fatigue—Prednisone—hematologic cancer	1.76e-05	6.82e-05	CcSEcCtD
Pentamidine—Headache—Prednisolone—hematologic cancer	1.76e-05	6.82e-05	CcSEcCtD
Pentamidine—Discomfort—Methotrexate—hematologic cancer	1.75e-05	6.81e-05	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—hematologic cancer	1.75e-05	6.81e-05	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—hematologic cancer	1.75e-05	6.81e-05	CcSEcCtD
Pentamidine—Syncope—Epirubicin—hematologic cancer	1.75e-05	6.8e-05	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—hematologic cancer	1.75e-05	6.78e-05	CcSEcCtD
Pentamidine—Constipation—Prednisone—hematologic cancer	1.74e-05	6.76e-05	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—hematologic cancer	1.72e-05	6.7e-05	CcSEcCtD
Pentamidine—Confusional state—Methotrexate—hematologic cancer	1.72e-05	6.66e-05	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—hematologic cancer	1.72e-05	6.66e-05	CcSEcCtD
Pentamidine—Dizziness—Triamcinolone—hematologic cancer	1.7e-05	6.62e-05	CcSEcCtD
Pentamidine—Cough—Epirubicin—hematologic cancer	1.7e-05	6.61e-05	CcSEcCtD
Pentamidine—Anaphylactic shock—Methotrexate—hematologic cancer	1.7e-05	6.61e-05	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—hematologic cancer	1.7e-05	6.61e-05	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—hematologic cancer	1.69e-05	6.57e-05	CcSEcCtD
Pentamidine—Infection—Methotrexate—hematologic cancer	1.69e-05	6.57e-05	CcSEcCtD
Pentamidine—Nausea—Etoposide—hematologic cancer	1.69e-05	6.55e-05	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—hematologic cancer	1.68e-05	6.54e-05	CcSEcCtD
Pentamidine—Feeling abnormal—Prednisone—hematologic cancer	1.68e-05	6.52e-05	CcSEcCtD
Pentamidine—Asthenia—Betamethasone—hematologic cancer	1.68e-05	6.52e-05	CcSEcCtD
Pentamidine—Asthenia—Dexamethasone—hematologic cancer	1.68e-05	6.52e-05	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—hematologic cancer	1.67e-05	6.48e-05	CcSEcCtD
Pentamidine—Thrombocytopenia—Methotrexate—hematologic cancer	1.67e-05	6.47e-05	CcSEcCtD
Pentamidine—Gastrointestinal pain—Prednisone—hematologic cancer	1.67e-05	6.47e-05	CcSEcCtD
Pentamidine—Nausea—Prednisolone—hematologic cancer	1.66e-05	6.46e-05	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—hematologic cancer	1.66e-05	6.45e-05	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—hematologic cancer	1.66e-05	6.45e-05	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—hematologic cancer	1.66e-05	6.45e-05	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—hematologic cancer	1.66e-05	6.43e-05	CcSEcCtD
Pentamidine—Pruritus—Dexamethasone—hematologic cancer	1.65e-05	6.43e-05	CcSEcCtD
Pentamidine—Pruritus—Betamethasone—hematologic cancer	1.65e-05	6.43e-05	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—hematologic cancer	1.64e-05	6.37e-05	CcSEcCtD
Pentamidine—Vomiting—Triamcinolone—hematologic cancer	1.64e-05	6.36e-05	CcSEcCtD
Pentamidine—Rash—Triamcinolone—hematologic cancer	1.63e-05	6.31e-05	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—hematologic cancer	1.63e-05	6.31e-05	CcSEcCtD
Pentamidine—Dermatitis—Triamcinolone—hematologic cancer	1.62e-05	6.3e-05	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—hematologic cancer	1.62e-05	6.3e-05	CcSEcCtD
Pentamidine—Anorexia—Methotrexate—hematologic cancer	1.62e-05	6.3e-05	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—hematologic cancer	1.62e-05	6.29e-05	CcSEcCtD
Pentamidine—Urticaria—Prednisone—hematologic cancer	1.62e-05	6.28e-05	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—hematologic cancer	1.62e-05	6.28e-05	CcSEcCtD
Pentamidine—Headache—Triamcinolone—hematologic cancer	1.61e-05	6.27e-05	CcSEcCtD
Pentamidine—Abdominal pain—Prednisone—hematologic cancer	1.61e-05	6.25e-05	CcSEcCtD
Pentamidine—Body temperature increased—Prednisone—hematologic cancer	1.61e-05	6.25e-05	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—hematologic cancer	1.61e-05	6.24e-05	CcSEcCtD
Pentamidine—Diarrhoea—Dexamethasone—hematologic cancer	1.6e-05	6.21e-05	CcSEcCtD
Pentamidine—Diarrhoea—Betamethasone—hematologic cancer	1.6e-05	6.21e-05	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—hematologic cancer	1.6e-05	6.2e-05	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—hematologic cancer	1.59e-05	6.19e-05	CcSEcCtD
Pentamidine—Hypotension—Methotrexate—hematologic cancer	1.59e-05	6.18e-05	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—hematologic cancer	1.59e-05	6.16e-05	CcSEcCtD
Pentamidine—Infection—Epirubicin—hematologic cancer	1.58e-05	6.14e-05	CcSEcCtD
Pentamidine—Cough—Doxorubicin—hematologic cancer	1.58e-05	6.12e-05	CcSEcCtD
Pentamidine—Shock—Epirubicin—hematologic cancer	1.57e-05	6.09e-05	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—hematologic cancer	1.56e-05	6.08e-05	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—hematologic cancer	1.56e-05	6.06e-05	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—hematologic cancer	1.56e-05	6.05e-05	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—hematologic cancer	1.55e-05	6.04e-05	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.55e-05	6.02e-05	CcSEcCtD
Pentamidine—Dizziness—Dexamethasone—hematologic cancer	1.55e-05	6.01e-05	CcSEcCtD
Pentamidine—Dizziness—Betamethasone—hematologic cancer	1.55e-05	6.01e-05	CcSEcCtD
Pentamidine—Insomnia—Methotrexate—hematologic cancer	1.54e-05	5.98e-05	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—hematologic cancer	1.54e-05	5.97e-05	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—hematologic cancer	1.54e-05	5.97e-05	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—hematologic cancer	1.54e-05	5.97e-05	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—hematologic cancer	1.53e-05	5.95e-05	CcSEcCtD
Pentamidine—Nausea—Triamcinolone—hematologic cancer	1.53e-05	5.94e-05	CcSEcCtD
Pentamidine—Paraesthesia—Methotrexate—hematologic cancer	1.53e-05	5.93e-05	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—hematologic cancer	1.52e-05	5.9e-05	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—hematologic cancer	1.52e-05	5.9e-05	CcSEcCtD
Pentamidine—Dyspnoea—Methotrexate—hematologic cancer	1.52e-05	5.89e-05	CcSEcCtD
Pentamidine—Somnolence—Methotrexate—hematologic cancer	1.51e-05	5.88e-05	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—hematologic cancer	1.5e-05	5.84e-05	CcSEcCtD
Pentamidine—Hypersensitivity—Prednisone—hematologic cancer	1.5e-05	5.83e-05	CcSEcCtD
Pentamidine—Dyspepsia—Methotrexate—hematologic cancer	1.5e-05	5.82e-05	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—hematologic cancer	1.49e-05	5.78e-05	CcSEcCtD
Pentamidine—Vomiting—Betamethasone—hematologic cancer	1.49e-05	5.77e-05	CcSEcCtD
Pentamidine—Vomiting—Dexamethasone—hematologic cancer	1.49e-05	5.77e-05	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—hematologic cancer	1.49e-05	5.77e-05	CcSEcCtD
Pentamidine—Decreased appetite—Methotrexate—hematologic cancer	1.48e-05	5.75e-05	CcSEcCtD
Pentamidine—Rash—Betamethasone—hematologic cancer	1.47e-05	5.73e-05	CcSEcCtD
Pentamidine—Rash—Dexamethasone—hematologic cancer	1.47e-05	5.73e-05	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.47e-05	5.72e-05	CcSEcCtD
Pentamidine—Dermatitis—Betamethasone—hematologic cancer	1.47e-05	5.72e-05	CcSEcCtD
Pentamidine—Dermatitis—Dexamethasone—hematologic cancer	1.47e-05	5.72e-05	CcSEcCtD
Pentamidine—Fatigue—Methotrexate—hematologic cancer	1.47e-05	5.7e-05	CcSEcCtD
Pentamidine—Headache—Dexamethasone—hematologic cancer	1.47e-05	5.69e-05	CcSEcCtD
Pentamidine—Headache—Betamethasone—hematologic cancer	1.47e-05	5.69e-05	CcSEcCtD
Pentamidine—Infection—Doxorubicin—hematologic cancer	1.46e-05	5.69e-05	CcSEcCtD
Pentamidine—Asthenia—Prednisone—hematologic cancer	1.46e-05	5.67e-05	CcSEcCtD
Pentamidine—Pain—Methotrexate—hematologic cancer	1.46e-05	5.65e-05	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.45e-05	5.64e-05	CcSEcCtD
Pentamidine—Shock—Doxorubicin—hematologic cancer	1.45e-05	5.63e-05	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.44e-05	5.6e-05	CcSEcCtD
Pentamidine—Pruritus—Prednisone—hematologic cancer	1.44e-05	5.6e-05	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—hematologic cancer	1.44e-05	5.59e-05	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—hematologic cancer	1.44e-05	5.59e-05	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—hematologic cancer	1.43e-05	5.55e-05	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—hematologic cancer	1.42e-05	5.51e-05	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—hematologic cancer	1.42e-05	5.5e-05	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—hematologic cancer	1.4e-05	5.46e-05	CcSEcCtD
Pentamidine—Feeling abnormal—Methotrexate—hematologic cancer	1.4e-05	5.45e-05	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—hematologic cancer	1.4e-05	5.44e-05	CcSEcCtD
Pentamidine—Diarrhoea—Prednisone—hematologic cancer	1.39e-05	5.41e-05	CcSEcCtD
Pentamidine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.39e-05	5.4e-05	CcSEcCtD
Pentamidine—Nausea—Dexamethasone—hematologic cancer	1.39e-05	5.39e-05	CcSEcCtD
Pentamidine—Nausea—Betamethasone—hematologic cancer	1.39e-05	5.39e-05	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—hematologic cancer	1.38e-05	5.38e-05	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—hematologic cancer	1.38e-05	5.35e-05	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—hematologic cancer	1.37e-05	5.33e-05	CcSEcCtD
Pentamidine—Pain—Epirubicin—hematologic cancer	1.36e-05	5.29e-05	CcSEcCtD
Pentamidine—Constipation—Epirubicin—hematologic cancer	1.36e-05	5.29e-05	CcSEcCtD
Pentamidine—Urticaria—Methotrexate—hematologic cancer	1.35e-05	5.25e-05	CcSEcCtD
Pentamidine—Dizziness—Prednisone—hematologic cancer	1.35e-05	5.23e-05	CcSEcCtD
Pentamidine—Body temperature increased—Methotrexate—hematologic cancer	1.35e-05	5.22e-05	CcSEcCtD
Pentamidine—Abdominal pain—Methotrexate—hematologic cancer	1.35e-05	5.22e-05	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.34e-05	5.21e-05	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—hematologic cancer	1.33e-05	5.18e-05	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—hematologic cancer	1.32e-05	5.14e-05	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—hematologic cancer	1.31e-05	5.1e-05	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—hematologic cancer	1.31e-05	5.1e-05	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—hematologic cancer	1.31e-05	5.09e-05	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.3e-05	5.06e-05	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—hematologic cancer	1.3e-05	5.04e-05	CcSEcCtD
Pentamidine—Vomiting—Prednisone—hematologic cancer	1.29e-05	5.03e-05	CcSEcCtD
Pentamidine—Rash—Prednisone—hematologic cancer	1.28e-05	4.99e-05	CcSEcCtD
Pentamidine—Dermatitis—Prednisone—hematologic cancer	1.28e-05	4.98e-05	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—hematologic cancer	1.28e-05	4.98e-05	CcSEcCtD
Pentamidine—Headache—Prednisone—hematologic cancer	1.28e-05	4.95e-05	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—hematologic cancer	1.27e-05	4.93e-05	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—hematologic cancer	1.27e-05	4.91e-05	CcSEcCtD
Pentamidine—Pain—Doxorubicin—hematologic cancer	1.26e-05	4.89e-05	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—hematologic cancer	1.26e-05	4.89e-05	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—hematologic cancer	1.26e-05	4.89e-05	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—hematologic cancer	1.26e-05	4.89e-05	CcSEcCtD
Pentamidine—Hypersensitivity—Methotrexate—hematologic cancer	1.25e-05	4.87e-05	CcSEcCtD
Pentamidine—Asthenia—Methotrexate—hematologic cancer	1.22e-05	4.74e-05	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—hematologic cancer	1.21e-05	4.72e-05	CcSEcCtD
Pentamidine—Nausea—Prednisone—hematologic cancer	1.21e-05	4.7e-05	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.21e-05	4.68e-05	CcSEcCtD
Pentamidine—Pruritus—Methotrexate—hematologic cancer	1.2e-05	4.68e-05	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—hematologic cancer	1.17e-05	4.56e-05	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—hematologic cancer	1.17e-05	4.55e-05	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—hematologic cancer	1.17e-05	4.52e-05	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—hematologic cancer	1.17e-05	4.52e-05	CcSEcCtD
Pentamidine—Diarrhoea—Methotrexate—hematologic cancer	1.16e-05	4.52e-05	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—hematologic cancer	1.14e-05	4.44e-05	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—hematologic cancer	1.13e-05	4.38e-05	CcSEcCtD
Pentamidine—Dizziness—Methotrexate—hematologic cancer	1.13e-05	4.37e-05	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—hematologic cancer	1.09e-05	4.23e-05	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—hematologic cancer	1.09e-05	4.22e-05	CcSEcCtD
Pentamidine—Vomiting—Methotrexate—hematologic cancer	1.08e-05	4.2e-05	CcSEcCtD
Pentamidine—Rash—Methotrexate—hematologic cancer	1.07e-05	4.17e-05	CcSEcCtD
Pentamidine—Dermatitis—Methotrexate—hematologic cancer	1.07e-05	4.16e-05	CcSEcCtD
Pentamidine—Headache—Methotrexate—hematologic cancer	1.07e-05	4.14e-05	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—hematologic cancer	1.06e-05	4.11e-05	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—hematologic cancer	1.05e-05	4.09e-05	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—hematologic cancer	1.04e-05	4.05e-05	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—hematologic cancer	1.01e-05	3.93e-05	CcSEcCtD
Pentamidine—Nausea—Methotrexate—hematologic cancer	1.01e-05	3.93e-05	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—hematologic cancer	1.01e-05	3.92e-05	CcSEcCtD
Pentamidine—Rash—Epirubicin—hematologic cancer	1e-05	3.9e-05	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—hematologic cancer	1e-05	3.9e-05	CcSEcCtD
Pentamidine—Headache—Epirubicin—hematologic cancer	9.98e-06	3.87e-05	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—hematologic cancer	9.75e-06	3.78e-05	CcSEcCtD
Pentamidine—Nausea—Epirubicin—hematologic cancer	9.46e-06	3.67e-05	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—hematologic cancer	9.37e-06	3.64e-05	CcSEcCtD
Pentamidine—Rash—Doxorubicin—hematologic cancer	9.29e-06	3.61e-05	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—hematologic cancer	9.28e-06	3.61e-05	CcSEcCtD
Pentamidine—Headache—Doxorubicin—hematologic cancer	9.23e-06	3.59e-05	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—hematologic cancer	8.75e-06	3.4e-05	CcSEcCtD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.84e-06	7.32e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTT1—hematologic cancer	5.81e-06	7.28e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CB—hematologic cancer	5.79e-06	7.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	5.79e-06	7.25e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—hematologic cancer	5.78e-06	7.25e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.78e-06	7.25e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NUP98—hematologic cancer	5.78e-06	7.24e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.77e-06	7.22e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.72e-06	7.17e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTAP—hematologic cancer	5.71e-06	7.16e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SDC1—hematologic cancer	5.68e-06	7.12e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.63e-06	7.05e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.63e-06	7.05e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ACP5—hematologic cancer	5.61e-06	7.03e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CA9—hematologic cancer	5.61e-06	7.03e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.61e-06	7.03e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.61e-06	7.03e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.59e-06	7e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CD44—hematologic cancer	5.58e-06	6.99e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NQO1—hematologic cancer	5.58e-06	6.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NUP214—hematologic cancer	5.57e-06	6.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.54e-06	6.94e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.51e-06	6.9e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.49e-06	6.87e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTR—hematologic cancer	5.46e-06	6.83e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCG2—hematologic cancer	5.46e-06	6.83e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.43e-06	6.8e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.36e-06	6.71e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO2—hematologic cancer	5.35e-06	6.7e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—hematologic cancer	5.31e-06	6.66e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NUP98—hematologic cancer	5.31e-06	6.66e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYCS—hematologic cancer	5.28e-06	6.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—IDH1—hematologic cancer	5.27e-06	6.61e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CD44—hematologic cancer	5.27e-06	6.6e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NQO1—hematologic cancer	5.27e-06	6.6e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.25e-06	6.57e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.21e-06	6.53e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TXN—hematologic cancer	5.21e-06	6.53e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.21e-06	6.53e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.19e-06	6.5e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.16e-06	6.47e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.16e-06	6.46e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.16e-06	6.46e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—hematologic cancer	5.14e-06	6.44e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.13e-06	6.42e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NUP214—hematologic cancer	5.12e-06	6.42e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.11e-06	6.4e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.1e-06	6.39e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—FHL2—hematologic cancer	5.09e-06	6.38e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SDC1—hematologic cancer	5.07e-06	6.35e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTR—hematologic cancer	5.02e-06	6.29e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.02e-06	6.29e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—hematologic cancer	5e-06	6.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.99e-06	6.26e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYCS—hematologic cancer	4.99e-06	6.25e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	4.96e-06	6.21e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO2—hematologic cancer	4.92e-06	6.17e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—hematologic cancer	4.92e-06	6.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.9e-06	6.14e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.85e-06	6.07e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NQO1—hematologic cancer	4.83e-06	6.05e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CD44—hematologic cancer	4.83e-06	6.05e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.78e-06	5.99e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.77e-06	5.98e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—EP300—hematologic cancer	4.77e-06	5.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.77e-06	5.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.77e-06	5.98e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.73e-06	5.93e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.73e-06	5.93e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.73e-06	5.93e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—hematologic cancer	4.71e-06	5.9e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SDC1—hematologic cancer	4.67e-06	5.84e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.65e-06	5.83e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.65e-06	5.82e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.58e-06	5.73e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYCS—hematologic cancer	4.57e-06	5.73e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.54e-06	5.69e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NUP98—hematologic cancer	4.5e-06	5.64e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.46e-06	5.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.45e-06	5.58e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.4e-06	5.52e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—hematologic cancer	4.4e-06	5.51e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.37e-06	5.47e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.37e-06	5.47e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—hematologic cancer	4.34e-06	5.44e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NUP214—hematologic cancer	4.34e-06	5.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CA9—hematologic cancer	4.33e-06	5.42e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.33e-06	5.42e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CD44—hematologic cancer	4.31e-06	5.4e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NQO1—hematologic cancer	4.31e-06	5.4e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.29e-06	5.38e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.28e-06	5.36e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.28e-06	5.36e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.27e-06	5.35e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.25e-06	5.33e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTR—hematologic cancer	4.25e-06	5.33e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.25e-06	5.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.22e-06	5.29e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO2—hematologic cancer	4.17e-06	5.22e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ABCB1—hematologic cancer	4.16e-06	5.21e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.09e-06	5.12e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYCS—hematologic cancer	4.08e-06	5.11e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—IDH1—hematologic cancer	4.07e-06	5.1e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.05e-06	5.08e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.04e-06	5.07e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—hematologic cancer	4.04e-06	5.06e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NCOR1—hematologic cancer	4.04e-06	5.06e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.03e-06	5.05e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.02e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.02e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TXN—hematologic cancer	4.02e-06	5.04e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.98e-06	4.99e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.97e-06	4.97e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CD44—hematologic cancer	3.97e-06	4.97e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.95e-06	4.95e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.94e-06	4.93e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.9e-06	4.88e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.81e-06	4.78e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.78e-06	4.74e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.78e-06	4.73e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.78e-06	4.73e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.75e-06	4.7e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.73e-06	4.67e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.73e-06	4.67e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.7e-06	4.64e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.7e-06	4.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.68e-06	4.61e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.68e-06	4.61e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.65e-06	4.57e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.6e-06	4.51e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.59e-06	4.49e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—hematologic cancer	3.57e-06	4.47e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.56e-06	4.47e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—hematologic cancer	3.53e-06	4.42e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.48e-06	4.36e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.47e-06	4.35e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.41e-06	4.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.37e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.37e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CD44—hematologic cancer	3.36e-06	4.21e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NQO1—hematologic cancer	3.36e-06	4.21e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.35e-06	4.2e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.31e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.31e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.31e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.29e-06	4.12e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.28e-06	4.11e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTR—hematologic cancer	3.28e-06	4.11e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.27e-06	4.1e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.22e-06	4.03e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYCS—hematologic cancer	3.18e-06	3.98e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.17e-06	3.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.16e-06	3.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.15e-06	3.94e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.13e-06	3.92e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.12e-06	3.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.05e-06	3.82e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.04e-06	3.81e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.04e-06	3.81e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—hematologic cancer	3e-06	3.76e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.94e-06	3.69e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.92e-06	3.66e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.88e-06	3.61e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—hematologic cancer	2.88e-06	3.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.84e-06	3.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.8e-06	3.51e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.79e-06	3.5e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.78e-06	3.48e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—hematologic cancer	2.76e-06	3.45e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.75e-06	3.44e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.71e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.69e-06	3.37e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.65e-06	3.32e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.64e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.64e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—hematologic cancer	2.6e-06	3.26e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.59e-06	3.25e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CD44—hematologic cancer	2.59e-06	3.25e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.58e-06	3.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.58e-06	3.23e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.57e-06	3.23e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.55e-06	3.19e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.49e-06	3.12e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.45e-06	3.07e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.45e-06	3.07e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.44e-06	3.05e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.43e-06	3.05e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.42e-06	3.03e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—hematologic cancer	2.39e-06	2.99e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.3e-06	2.88e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.28e-06	2.86e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.28e-06	2.85e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.28e-06	2.85e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.26e-06	2.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.16e-06	2.71e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.16e-06	2.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—hematologic cancer	2.13e-06	2.67e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.11e-06	2.64e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—hematologic cancer	2.1e-06	2.63e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.09e-06	2.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.05e-06	2.57e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.04e-06	2.55e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.01e-06	2.51e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—EP300—hematologic cancer	2e-06	2.51e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.99e-06	2.49e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.99e-06	2.49e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—hematologic cancer	1.99e-06	2.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.98e-06	2.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—hematologic cancer	1.96e-06	2.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.91e-06	2.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—EP300—hematologic cancer	1.89e-06	2.37e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.88e-06	2.36e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.87e-06	2.35e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.82e-06	2.28e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.77e-06	2.22e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.76e-06	2.2e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—EP300—hematologic cancer	1.74e-06	2.18e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.73e-06	2.17e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.68e-06	2.11e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—hematologic cancer	1.66e-06	2.08e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.63e-06	2.04e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.59e-06	1.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—EP300—hematologic cancer	1.55e-06	1.94e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.49e-06	1.87e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.48e-06	1.86e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.48e-06	1.85e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.47e-06	1.84e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—EP300—hematologic cancer	1.43e-06	1.79e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.4e-06	1.76e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.37e-06	1.71e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.3e-06	1.63e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.28e-06	1.61e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—hematologic cancer	1.28e-06	1.6e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.27e-06	1.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.23e-06	1.53e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.21e-06	1.52e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—EP300—hematologic cancer	1.21e-06	1.51e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.15e-06	1.44e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—hematologic cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.13e-06	1.42e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.05e-06	1.32e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—hematologic cancer	1.05e-06	1.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—hematologic cancer	9.77e-07	1.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—hematologic cancer	9.37e-07	1.17e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EP300—hematologic cancer	9.32e-07	1.17e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.93e-07	1.12e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—hematologic cancer	8.61e-07	1.08e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—hematologic cancer	7.3e-07	9.14e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.89e-07	8.64e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.63e-07	7.06e-06	CbGpPWpGaD
